Mercer Global Advisors’s ROBO Global Healthcare Technology and Innovation ETF HTEC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-9,409
Closed -$280K 1976
2023
Q1
$280K Sell
9,409
-1,430
-13% -$43K ﹤0.01% 1554
2022
Q4
$313K Sell
10,839
-1,031
-9% -$29.5K ﹤0.01% 1480
2022
Q3
$321K Buy
11,870
+1,215
+11% +$37.1K ﹤0.01% 1364
2022
Q2
$309K Sell
10,655
-310
-3% -$9.6K ﹤0.01% 1408
2022
Q1
$399K Buy
10,965
+368
+3% +$13.6K ﹤0.01% 1354
2021
Q4
$462K Sell
10,597
-740
-7% -$33.1K ﹤0.01% 1253
2021
Q3
$517K Buy
+11,337
New +$540K ﹤0.01% 1150
2021
Q1
Sell
-11,693
Closed -$511K 1646
2020
Q4
$511K Sell
11,693
-1,886
-14% -$73.8K 0.01% 849
2020
Q3
$418K Buy
+13,579
New +$456K 0.01% 844
2020
Q2
Sell
-13,635
Closed -$320K 1080
2020
Q1
$320K Buy
+13,635
New +$353K 0.01% 785

Other funds holding HTEC

Mercer Global Advisors's HTEC Position: Q2 2023 in Review

Mercer Global Advisors sold out of ROBO Global Healthcare Technology and Innovation ETF (HTEC) in Q2 2023, closing a stake of 9,409 shares — an estimated $280K sold.

Mercer Global Advisors first reported a position in HTEC in Q1 2020 and held it in 10 quarters. The position peaked at $517K in Q3 2021. 35 funds tracked by Wall St. Rank hold HTEC as of Q2 2023.

  • Mercer Global Advisors reported no remaining ROBO Global Healthcare Technology and Innovation ETF position as of Q2 2023 after selling out during the quarter.
  • Mercer Global Advisors sold 9,409 ROBO Global Healthcare Technology and Innovation ETF shares in Q2 2023, an estimated $280K.
  • Mercer Global Advisors first reported a position in ROBO Global Healthcare Technology and Innovation ETF in Q1 2020 and held it in 10 quarters.
  • Mercer Global Advisors's ROBO Global Healthcare Technology and Innovation ETF position peaked at $517K in Q3 2021.
  • 35 funds tracked by Wall St. Rank held ROBO Global Healthcare Technology and Innovation ETF as of Q2 2023.

Based on Mercer Global Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.